Hepatocellular carcinoma (HCC), the most common form of liver cancer, continues to pose a significant global health challenge ...

LIVER CANCER, the third leading cause of cancer-related deaths globally, is primarily attributed to hepatocellular carcinoma ...

Systemic therapy represents the standard of care treatment for patients with advanced hepatocellular carcinoma (HCC). Given ...

During a Community Case Forum event, Stacey Stein, MD, discussed data guiding the use of current regimens for the treatment ...

Long-term use of statins may delay or deflect the development of hepatocellular carcinoma in adults with chronic liver disease, as well as in the general population, emerging research, including ...

Hepatocellular carcinoma (HCC) is the most prevalent form ... The role of systemic therapies in the management of HCC is expanding, and future research will likely focus on refining selection ...

Hepatocellular carcinoma (HCC), the most common type of ... and/or metformin for the management of comorbid conditions. These medications are relatively inexpensive and prior data has shown ...

As India marks World Liver Day, health experts are raising concerns over the rising burden of liver cancer, a disease often ...

Hepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive diagnostic/prognostic biomarkers for early detection of HCC are still lacking.

Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC) are respectively the first and the second most common pediatric malignant liver tumors. The purpose of this study was to ...

Hepatocellular carcinoma (HCC) represents a significant ... which is crucial for appropriate clinical management. Borderline ...